August 3, 2017 / 9:00 PM / 7 months ago

BRIEF-Ironwood Pharmaceuticals Q2 loss per share $0.30

Aug 3 (Reuters) - Ironwood Pharmaceuticals Inc

* Ironwood Pharmaceuticals provides second quarter 2017 investor update

* Q2 non-GAAP loss per share $0.28

* Q2 loss per share $0.30

* Q2 revenue $65.1 million versus I/B/E/S view $70.8 million

* Q2 earnings per share view $-0.22 -- Thomson Reuters I/B/E/S

* Ironwood Pharmaceuticals - sees ‍combined Allergan, Ironwood total 2017 marketing and sales expenses for Linzess to be in range of $250 million to $280 million​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below